202062

Other Takehiko Kaneko was appointed as Chief Medical Officer (CMO)

2020310

PR Announced Capital and Business Alliance with MEDIPAL HOLDINGS

2020310

PR Announced Capital Alliance with ITOCHU CHEMICAL FRONTIER

2020130

Other Kay Deguchi was appointed as Independent Director

2020129

Media Links of Keiichi Fukuda' interviews were posted at CEO Message.

20191122

PR Heartseed raises $26 Million in Series B Funding

2019109

Other Akira Fujiyoshi was appointed as External Auditor

2019129

Other Kikuo Yasui was appointed as COO

2018930

Other Tomoyuki Kikugawa was appointed as External Auditor (full-time)

2018918

PR Heartseed Inc. was selected as one of the subsidy program of Japan Agency for Medical Research and Development (AMED), supporting Research Project for Practical Applications of Regenerative Medicine